Case Series of StimLabs Dehydrated Human Umbilical Cord Particulate for Acute and Chronic Wounds

Part of paid clinical trials in Bridgeport, Connecticut.

Sponsor
StimLabs
Study ID
NCT07414368
Status
Enrolling By Invitation

Conditions

  • Chronic Ulcers
  • DFU
  • Diabetic Foot Ulcers (DFU)
  • Ulcer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Corplex P is used to cover, protect, and provide a moist wound environment — DEVICE
    Corplex P is derived from human birth tissue and used in wound management to cover, protect, and provide a moist wound environment.

Study Details

The purpose of this observational case series is to assess the use of Corplex P as a resorbable particulate device used to cover, protect, and provide a moist wound environment when added to the standard of care treatment of hard-to-heal wounds.

Key Dates

Start date
Feb 11, 2026
Status verified
Dec 2025
Primary completion
Jun 30, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
10 participants (estimated)

Arms

  • Arm: Retrospective Corplex P
    Retrospective case review of subjects receiving Corplex P

Primary Outcome Measure

The proportion of target ulcers achieving complete wound closure during the observational period [ Time Frame: 1-12 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Family Foot & Ankle Specialists, LLCBridgeportConnecticut06606-

Find similar trials in Bridgeport, CT

Related Studies